Pfizer

News

Vydura is NHS’ first oral CGRP for migraine prevention

Pfizer’s Vydura has become the first oral CGRP antagonist recommended for routine use by the NHS to prevent episodic migraine attacks, after being rejected earlier this ye

News

Pfizer says haemophilia drug works, but safety will be key

Pfizer has reported that its anti-tissue factor pathway inhibitor marstacimab is effective at reducing bleed rates in patients with haemophilia A and B, working as well as

News

FDA advisors back Pfizer’s RSV shot for maternal use

An FDA advisory committee has endorsed Pfizer’s respiratory syncytial virus (RSV) vaccine for use in expectant mothers, potentially opening up a niche for the shot, where

News

GSK chases down Pfizer in 5-in-1 meningitis jab contest

Armed with new data, GSK is preparing to file for approval of its new-generation meningitis vaccine, as it tries to maintain its leadership in the category against a chall

News

FDA advisors narrowly back Sarepta’s Duchenne gene therapy

An FDA advisory committee has given tentative backing to Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD), even though the agency’s reviewers said they were no

News

Caution urged as Pfizer’s maternal RSV shot adcomm nears

There have been calls for caution when it comes to the use of Pfizer’s respiratory syncytial virus (RSV) vaccine in pregnant women, ahead of an FDA advisory committee meet

Vydura is NHS’ first oral CGRP for migraine prevention

Pfizer says haemophilia drug works, but safety will be key

FDA advisors back Pfizer’s RSV shot for maternal use

GSK chases down Pfizer in 5-in-1 meningitis jab contest

FDA advisors narrowly back Sarepta’s Duchenne gene therapy

Caution urged as Pfizer’s maternal RSV shot adcomm nears

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Pfizer

Editor's Picks